Here, we identified METTL7B as an essential regulator of lineage specification and an epigenetic modulator of the expression of the transcription factor SALL2 with wide-ranging impact on invasion and tumor growth in glioblastoma. The gene discussed is TMT1B; the disease is neoplasm.